Traphagen Investment Advisors LLC Sells 8,096 Shares of Goldman Sachs Innovate Equity ETF (NYSEARCA:GINN)

Traphagen Investment Advisors LLC lessened its stake in shares of Goldman Sachs Innovate Equity ETF (NYSEARCA:GINN) by 26.3% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 22,685 shares of the company’s stock after selling 8,096 shares during the quarter. Traphagen Investment Advisors LLC’s holdings in Goldman Sachs Innovate Equity ETF were worth $1,396,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of GINN. Watts Gwilliam & Co. LLC acquired a new stake in shares of Goldman Sachs Innovate Equity ETF during the 3rd quarter valued at $777,000. Flow Traders U.S. LLC bought a new position in Goldman Sachs Innovate Equity ETF in the third quarter valued at about $1,767,000. Finally, Highland Financial Advisors LLC boosted its stake in shares of Goldman Sachs Innovate Equity ETF by 7.2% during the third quarter. Highland Financial Advisors LLC now owns 238,368 shares of the company’s stock valued at $14,548,000 after purchasing an additional 15,954 shares in the last quarter.

Goldman Sachs Innovate Equity ETF Trading Up 1.4 %

NYSEARCA:GINN opened at $63.79 on Wednesday. The stock’s 50-day moving average is $63.18 and its 200-day moving average is $60.55. Goldman Sachs Innovate Equity ETF has a 1-year low of $51.47 and a 1-year high of $65.80. The stock has a market cap of $401.88 million, a P/E ratio of 26.00 and a beta of 1.25.

Goldman Sachs Innovate Equity ETF Profile

The Goldman Sachs Innovate Equity ETF (GINN) is an exchange-traded fund that is based on the Solactive Innovative Global Equity index. The fund selects companies globally, believed to benefit from technological innovation and changes in the economy across five themes: data, finance, human evolution, manufacturing, and shifts with consumers.